Shenzhen RuiJin Pharmaceutical Co.,Ltd 86-188-06592208 Gavin@hgh-steroid.com
White Avodart Dutasteride Hair Loss Treatment Powder

White Avodart Dutasteride Hair Loss Treatment Powder

  • High Light

    164656-23-9

    ,

    Dutasteride Hair Loss Treatment Powder

    ,

    Avodart Hair Loss Treatment Powder

  • Other Name
    Avodart
  • Product name
    Dutasteride
  • CAS 
    164656-23-9
  • Molecular formula
    C27H30F6N2O2
  • Molecular weight
    528.53
  • Melting Point
    42-250℃
  • Flash Point
    28.954°C
  • Email
    Gavin@pharmrich.com
  • Place of Origin
    China
  • Brand Name
    RuiiJin
  • Certification
    ISO9001
  • Model Number
    164656-23-9
  • Minimum Order Quantity
    10g
  • Price
    Negotiable
  • Packaging Details
    Disguised package or according to your requirement
  • Delivery Time
    Within 48hours after payment
  • Payment Terms
    Western union and moneygram,Bank transfer,Bitcoin,
  • Supply Ability
    3000kg/month

White Avodart Dutasteride Hair Loss Treatment Powder

White Avodart Dutasteride Hair Loss Treatment Powder

 

Dutasteride Quick Detail:

 

Product name : Dutasteride
Other name : DUTASTERIDE; Duagen; Avodart
CAS : 164656-23-9
Molecular formula: C27H30F6N2O2
Molecular weight: 528.53
Melting point: 242°C~250°C
  White Avodart Dutasteride Hair Loss Treatment Powder 0
Packing: as your require
Appearance: White to pale yellow powder.
Storage: shading, confined preservation.
Usage: Prostate enlargement, male pattern hair loss, seborrheic alopecia, hereditary hair loss

 

 

 

Dutasteride VS Finasteride

 

Dutasteride and finasteride are very similar drugs. The following table lists their features.

  Dutasteride Finasteride
Use treatment of benign prostatic hyperplasia treatment of benign prostatic hyperplasia*
Is a generic version available? yes yes
Form capsule tablet
Strength 0.5 mg 5 mg
How do I take it? by mouth by mouth
How often do I take it? once daily once daily
Do I take it for long-term or short-term treatment? long term** long term**
How do I store it? between 68°F and 77°F (20°C and 25°C) between 68°F and 77°F (20°C and 25°C)

*Finasteride can also be used to treat male pattern hair loss.
**Treatment usually continues for the rest of your life.

 The main difference between dutasteride and finasteride is the intensity of the effect. Finasteride 1mg blocks about 70% of DHT, whereas dutasteride 0.5mg blocks more than 90%. This means that dutasteride is more effective at stopping the conversion of testosterone into DHT. Since DHT is what causes hair loss, this results in more hair regrowth and thickening of existing miniaturized hairs compared to finasteride.

 

How to use Anastrozole / Arimidex

 

  • 1. For men:

Anastrozole / Arimidex has been tested for reducing estrogens, including estradiol, in men. Excess estradiol in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism. It can also contribute to increased risk of stroke, heart attack, chronic inflammation, prostate enlargement and prostate cancer. Some athletes and body builders use Anastrozole / Arimidex as part of their steroid cycle to reduce and prevent symptoms of excess estrogen–gynecomastia, emotional lability and water retention. Study data suggests dosages of 0.5 mg to 1 mg a day reduce serum estradiol approx. 50% in men, which differs in postmenopausal women.

 

  • 2. For children:

Anastrozole / Arimidex may be used off-label in children with precocious puberty, or children with pubertal gynecomastia.Following the onset of puberty, the epiphyseal plate begins to close due to an increased amount of estrogen production escaping local metabolism and spreading to the circulatory system. It is shown to help slow this process, and increase adult height prediction in adolescent males treated with protein-based peptide hormones for the treatment of growth hormone deficiency.

 

1, Increasing the time before the cancer comes back in those who experience recurrence
2, Reducing the risk of the cancer spreading to other parts of the body
3, Reducing the risk of a new cancer developing in the other breast